Published as part of the Special Topic Synthesis in Industry
Abstract
Controlling the absolute and relative stereochemistry of a seven-membered oxepane
in the formation of HIV integrase inhibitor MK-1376 was accomplished through a strategy
involving the use of asymmetric allylation and stereoconvergent, substrate-directed
installation of an amine fragment. Surprising reactivity was demonstrated during the
asymmetric allylation in which the allyl-pyrimidone product was formed reversibly.
The stereoconvergent amine addition was accomplished through an elimination/addition
sequence involving a quinone methide reactive intermediate, and nucleophilic trapping
of the reactive quinone methide intermediate with methylamine. This novel approach
delivered MK-1376, offering 100-fold greater productivity and 50-fold less waste than
the initial synthetic chemistry route.
Key words
HIV integrase inhibitor - oxepane - pyrimidine - π-allyl cyclization - quinone methide